Items where authors include "Thomas, R.B."

Article

Cork, M.J., Thaçi, D., Eichenfield, L.F. et al. (8 more authors) (2023) Dupilumab safety and efficacy in a phase III open-label extension trial in children 6–11 years of age with severe atopic dermatitis. Dermatology and Therapy, 13. pp. 2697-2719. ISSN 2193-8210

Siegfried, E.C., Cork, M.J., Katoh, N. et al. (6 more authors) (2023) Dupilumab provides clinically meaningful responses in children aged 6–11 years with severe atopic dermatitis: post hoc analysis results from a phase III trial. American Journal of Clinical Dermatology, 24 (5). pp. 787-798. ISSN 1175-0561

Flohr, C. orcid.org/0000-0003-4884-6286, Irvine, A.D. orcid.org/0000-0002-9048-2044, Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (6 more authors) (2023) Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis. British Journal of Dermatology, 189 (2). pp. 238-240. ISSN 0007-0963